1. Adaptive immunity in pulmonary sarcoidosis and chronic beryllium disease;Greaves;Front Immunol,2020
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999;Am J Respir Crit Care Med,1999
3. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders;Hunninghake;Sarcoidosis Vasc Diffuse Lung Dis,1999
4. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression;Linke;Nat Immunol,2017
5. Advances in understanding the immunopathology of sarcoidosis and implications on therapy;Cinetto;Expert Rev Clin Immunol,2016